Torres, Antoni <br/><br/>
Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.  [electronic resource] 

 -  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  May 2008 
 - 1499-509 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1537-6591 
<br/><br/><label>Standard No.: </label>10.1086/587519  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Anti-Bacterial Agents--administration & dosage<br/>Aza Compounds--administration & dosage<br/>Bacteria--isolation & purification<br/>Ceftriaxone--administration & dosage<br/>Community-Acquired Infections--drug therapy<br/>Double-Blind Method<br/>Drug Therapy, Combination<br/>Female<br/>Fluoroquinolones<br/>Humans<br/>Levofloxacin<br/>Male<br/>Middle Aged<br/>Moxifloxacin<br/>Ofloxacin--administration & dosage<br/>Pneumonia, Bacterial--drug therapy<br/>Prospective Studies<br/>Quinolines--administration & dosage<br/>Severity of Illness Index<br/>Treatment Outcome